Latest filing published 05 Dec 2023 for Neuland Laboratories Limited, €29k.
Filing timeline
BuySaleNirupama Sundar: trading record in brief
All filings by Nirupama Sundar on record concern Neuland Laboratories Limited. In total, 2 filings cover trades dated from 17 August 2022 to 4 December 2023.
Both buying and selling appear: 1 purchase worth €13k, against 1 sale worth €29k. Taken together, the sales exceed the purchases by €16k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2023 to date brings no purchases and 1 sale.
On 5 December 2023 came the latest disclosure, an open-market sale for €29k in Neuland Laboratories Limited. The last purchase on record was published on 29 August 2022, which is 1,532 days ago. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Nirupama Sundar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 500 shares@ ₹5,375.31269.5% of flowEquity SharesSEBI:b62e4f859a13673fd4787828021ac0c5086cce7c
- 900 shares@ ₹1,154.543330.5% of flowEquity SharesSEBI:11b365ddbec7d14c614a7c28d07a379bc376bc6fCanonical exit: 15 Nov 2022 (T+90)
2 of 2 declarations